Published in Gut on May 01, 1996
Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg (2005) 1.99
Pathogenesis of ECL cell tumors in humans. Yale J Biol Med (1999) 1.04
Relationship of ECL cells and gastric neoplasia. Yale J Biol Med (1999) 0.87
Metastatic type 1 gastric carcinoid: a real threat or just a myth? World J Gastroenterol (2013) 0.85
Gastric carcinoids: between underestimation and overtreatment. World J Gastroenterol (2009) 0.83
Hypergastrinemia and enterochromaffin-like cell hyperplasia. Yale J Biol Med (1999) 0.83
Somatostatin analogs for gastric carcinoids: For many, but not all. World J Gastroenterol (2015) 0.79
Diagnosis and treatment of ECL cell tumors. Yale J Biol Med (1999) 0.77
The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev (1991) 2.20
Toxicological studies on omeprazole. Scand J Gastroenterol Suppl (1985) 2.19
Histopathological classification of nonantral gastric endocrine growths in man. Digestion (1988) 1.85
Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology (1985) 1.57
Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer (1991) 1.42
Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest (1994) 1.32
Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol (1995) 1.29
Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology (1990) 1.23
Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology (1992) 1.22
Proliferation of enterochromaffinlike cells in omeprazole-treated hypergastrinemic rats. Gastroenterology (1989) 1.16
Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol (1990) 1.10
Acute responses of rat stomach enterochromaffinlike cells to gastrin: secretory activation and adaptation. Gastroenterology (1994) 1.08
Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut (1992) 1.03
Composite carcinoid-adenocarcinoma of the stomach associated with multiple gastric carcinoids and nonantral gastric atrophy. Cancer (1989) 1.03
The somatostatin receptor subtype on rat enterochromaffinlike cells. Gastroenterology (1994) 0.97
Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology (1989) 0.97
Quantitative electron microscopy of endocrine cells in oxyntic mucosa of normal human stomach. Cell Tissue Res (1989) 0.96
Reversal by antrectomy of endocrine cell hyperplasia in the gastric body in pernicious anemia: a morphometric study. Mod Pathol (1990) 0.93
Serum gastrin concentration affects the self replication rate of the enterochromaffin like cells in the rat stomach. Gut (1990) 0.93
Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria. Gastroenterology (1992) 0.92
Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report. Surgery (1988) 0.91
Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol Suppl (1991) 0.91
Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings. Gastroenterology (1990) 0.88
Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis. Gastroenterology (1989) 0.88
Morphometry of gastric endocrine cells in hypergastrinemic patients treated with the somatostatin analogue octreotide. Regul Pept (1993) 0.86
Somatostatin receptors on canine fundic D-cells: evidence for autocrine regulation of gastric somatostatin. Am J Physiol (1989) 0.81
Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome. Eur J Clin Invest (1993) 0.81
Gastrin-dependent inhibitory effects of octreotide on the genesis of gastric ECLomas. Surgery (1992) 0.81
Self-replication of enterochromaffin-like cells in the mouse stomach. Digestion (1990) 0.81
Action of somatostatin analogue (SMS 201-995) on the growth-promoting effect resulting from sustained achlorhydria in rat gastric mucosa, with special reference to endocrine cell behaviour. Eur J Clin Invest (1988) 0.80
Neuroendocrine cell hyperplasia and neuroendocrine carcinoma of the rodent fundic stomach. Mutat Res (1991) 0.80
Ultrastructural morphometry of gastric endocrine cells before and after omeprazole. A study in the oxyntic mucosa of duodenal ulcer patients. Gastroenterology (1991) 0.79
Inhibition of gastrin-stimulated enterochromaffin-like cell proliferation and mucosal histamine production in the rat stomach by the somatostatin analogue octreotide. Regul Pept (1995) 0.78
Gastric carcinoid tumor and its precursor lesions. Ultrastructural study of a case before and after antrectomy. Arch Pathol Lab Med (1994) 0.77
Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G-cell hyperfunction. Aliment Pharmacol Ther (1994) 0.77
Effects of proglumide and enprostil on omeprazole-induced fundic endocrine cell hyperplasia in rats. Gastroenterol Clin Biol (1993) 0.77
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg (1996) 2.69
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol (2004) 2.54
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49
Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther (2012) 2.10
Histological recovery and gluten-free diet adherence: a prospective 1-year follow-up study of adult patients with coeliac disease. Aliment Pharmacol Ther (2014) 2.09
Histopathological classification of nonantral gastric endocrine growths in man. Digestion (1988) 1.85
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology (1999) 1.66
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst (2012) 1.65
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. Br J Surg (2012) 1.58
Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2001) 1.50
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma. Ann Oncol (2005) 1.49
Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Oncol (2013) 1.47
Rhabdomyolysis due to severe hypokaliemia in a Crohn's disease patient after budesonide treatment. Dig Liver Dis (2006) 1.41
Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study. Ital J Gastroenterol Hepatol (1997) 1.40
Hypersecretory duodenal ulcer and Helicobacter pylori infection: a four-year follow-up study. Dig Liver Dis (2000) 1.39
Reversible sustained increase of gastrin and gastric acid secretion in a subgroup of duodenal ulcer patients on long-term treatment with H2 antagonists. J Clin Gastroenterol (1991) 1.39
Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis. Ann Intern Med (1999) 1.38
[Who needs a gastroenterology pathologist?]. Pathologica (1996) 1.38
Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia (1994) 1.34
Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopy. Aliment Pharmacol Ther (2009) 1.32
Efficacy of gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients. Am J Gastroenterol (2001) 1.31
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin. Br J Cancer (2013) 1.10
Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med (1999) 1.10
Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets. Endocr Relat Cancer (2006) 1.10
Ampullary adenocarcinoma in neurofibromatosis type 1. Case report and literature review. Mod Pathol (2001) 1.09
Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome. Arch Pathol (1974) 1.09
Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report. Dig Liver Dis (2011) 1.09
Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther (2000) 1.07
Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy. Br J Cancer (2007) 1.07
Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway. Oncogene (2012) 1.05
Classification of gastric neuroendocrine tumors and its clinicopathologic significance. World J Gastroenterol (1998) 1.03
Large hiatal hernia in patients with iron deficiency anaemia: a prospective study on prevalence and treatment. Aliment Pharmacol Ther (2004) 1.03
The stomach and iron deficiency anaemia: a forgotten link. Dig Liver Dis (2003) 1.03
Composite carcinoid-adenocarcinoma of the stomach associated with multiple gastric carcinoids and nonantral gastric atrophy. Cancer (1989) 1.03
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection. Scand J Gastroenterol (1997) 1.02
Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter (2001) 1.01
Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? Aliment Pharmacol Ther (2001) 1.01
Role of Helicobacter pylori infection in pernicious anaemia. Dig Liver Dis (2000) 1.01
Heterotopic mesenteric ossification ('intraabdominal myositis ossificans'): report of five cases. Am J Surg Pathol (1999) 1.00
Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Eur J Gastroenterol Hepatol (2001) 1.00
Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia (1994) 1.00
Letter: ECL cell proliferation and gastrin levels. Gastroenterology (1975) 1.00
Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories. Aliment Pharmacol Ther (2007) 0.99
RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours. J Pathol (2005) 0.99
Consequences of Helicobacter pylori infection on the absorption of micronutrients. Dig Liver Dis (2002) 0.99
Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther (2010) 0.98
High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: a prospective screening study. Am J Gastroenterol (1999) 0.98
Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter (1997) 0.98
Quantitative electron microscopy of endocrine cells in oxyntic mucosa of normal human stomach. Cell Tissue Res (1989) 0.96
Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination? Ann Oncol (2006) 0.95
Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther (2005) 0.95
Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors. J Endocrinol Invest (2004) 0.94
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort. Ann Oncol (2011) 0.94
Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab (1993) 0.94
Effect of bombesin on plasma insulin, pancreatic glucagon, and gut glucagon in man. J Clin Endocrinol Metab (1983) 0.92
Symptom-based approach to colorectal cancer: survey of primary care physicians in Italy. Dig Liver Dis (2003) 0.92
Pathologic changes of endocrine cells in chronic atrophic gastritis. An ultrastructural study on peroral gastric biopsy specimens. Arch Pathol Lab Med (1978) 0.92
TorC apocytochrome negatively autoregulates the trimethylamine N-oxide (TMAO) reductase operon in Escherichia coli. Mol Microbiol (1999) 0.92
First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done? Gastrointest Endosc (2001) 0.92
Diagnosis and treatment of acute pancreatitis: the position statement of the Italian Association for the study of the pancreas. Dig Liver Dis (2008) 0.91
Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p. J Pathol (1998) 0.91
Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with Helicobacter pylori infection. Aliment Pharmacol Ther (2001) 0.91
Effect of bombesin-stimulated gastrin on gastric acid secretion in man. Life Sci (1980) 0.89
Effects of bombesin on gastrin and gastric acid secretion in patients with duodenal ulcer. Gut (1983) 0.89
Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings. Gastroenterology (1990) 0.88
Upper and lower gastrointestinal causes of iron deficiency anemia in elderly compared with adult outpatients. Minerva Gastroenterol Dietol (2010) 0.88